Company Seeks Federal Approval to Manufacture Controlled Painkiller
Published Date: 11/5/2026
Notice
Summary
Navinta LLC wants to become a big-time maker of a strong medicine called Remifentanil, which is tightly controlled by the government. People and companies involved with this drug can share their thoughts or ask for a hearing by January 4, 2027. This move could affect how this medicine is made and shared, but no extra activities are allowed beyond manufacturing.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-22553, Importer of Controlled Substances Application: Noramco
Noramco wants to become an official importer of some controlled substances like marijuana and methadone. People who make or apply to handle these drugs can share their thoughts or ask for a hearing by December 7, 2026. This move could affect companies dealing with these substances and involves a formal review process with no immediate cost changes announced.
2026-22555, Importer of Controlled Substances Application: Diamond Animal Health, Inc.
Diamond Animal Health, Inc. wants to become an official importer of a controlled drug called Pentobarbital, which is used in animal health. People who make or use these drugs can share their thoughts or ask for a hearing by December 7, 2026. This move could affect businesses handling these substances and involves careful government review but no direct costs mentioned yet.
Previous / Next Documents
Previous: 2026-22555, Importer of Controlled Substances Application: Diamond Animal Health, Inc.
Diamond Animal Health, Inc. wants to become an official importer of a controlled drug called Pentobarbital, which is used in animal health. People who make or use these drugs can share their thoughts or ask for a hearing by December 7, 2026. This move could affect businesses handling these substances and involves careful government review but no direct costs mentioned yet.
Next: 2026-22557, Proposed Information Collection Activity; Information Comparison With Insurance Data
The Office of Child Support Enforcement wants to keep matching insurance data with child support records for three more years but with less paperwork—cutting the burden by over 43%! This helps agencies collect unpaid child support from insurance payouts faster. Insurers and related agencies should note the updated rules and get ready to comment by January 4, 2027.